pharmacies until at least 2032 because of Novo Nordisks patent protections
, 275 , 18248-18258 (2000) (DOI: 10.1074/jbc.M000271200)
A recent study revealed that the occurrence of pancreatitis in diabetic patients can be attributed to a combination of various factors, including the disease itself, patient-related factors, and the administration of therapeutic agents
Once generics hit, public systems are likely to pivot quickly, switching patients to cheaper versions
PubMed Central , Biological Chemistry , vol
Clinical trials show that higher doses correlate with greater weight losspatients on 15 mg lost approximately 20% of body weight over 68 weeks compared to lower starting doses